Diarylether derivatives as antitumor agents

Details for Australian Patent Application No. 2006323700 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Otsuji, Shun; Yamada, Satoshi; Takasu, Hideki; Kojima, Yutaka; Motoyama, Masaaki; Kan, Keizo; Miyajima, Keisuke; Sakamoto, Makoto; Matsuyama, Hironori; Kodama, Takeshi; Sumida, Takumi; Higuchi, Kumi; Yasumura, Koichi; Ohnishi, Kenji; Nakagawa, Takashi

Agent Davies Collison Cave

Pub. Number AU-B-2006323700

PCT Pub. Number WO2007/066784

Priority 2005-351255 05.12.05 JP

Filing date 4 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 17 February 2011

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/066784 Priority application(s): WO2007/066784

17 February 2011 Application Accepted

  Published as AU-B-2006323700

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006323706-Genetically recombinant anti-PERP antibody

2006323695-Novel lipase